Trial Site Detail

 

Drug:
Trametinib + Palbociclib
Trial:
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Terminated

 

Vanderbilt-Ingram Cancer Center

2220 Pierce Ave.     691 Preston Building
Nashville , TN 37232
USA

 

Principal Investigator:
Contact:
615-322-4967
Activation Status of this Site:
Closed
Notes about this Site:
Vanderbilt-Ingram Cancer Center Website:
http://www.vicc.org/ct/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.